BRIEF published on 07/30/2026 at 21:54, 12 days 9 hours ago Ikonisys SA announces promising annual results for 2025 Financial Results Growth Ikonisys ALIKO SCIENTIFIC Oncological Diagnosis
BRIEF published on 07/30/2026 at 21:54, 12 days 9 hours ago Ikonisys SA Reports Increased Revenues and Developments in 2025 Revenue Growth Ikonisys SA Oncology Diagnostics ALIKO SCIENTIFIC Financial Results 2025
PRESS RELEASE published on 07/30/2026 at 21:49, 12 days 9 hours ago Inside Information / News release on accounts, results Aliko Scientific (Ikonisys SA) reports 52.6% increase in total revenue to €1.64 million and 32.9% improvement in EBITDA for 2025. Developments include US patent for ACTA, launch of Urine24, and agreement with Menarini Diagnostics Financial Results Revenue Increase EBITDA Improvement Oncology Diagnostics ALIKO SCIENTIFIC
BRIEF published on 07/23/2026 at 07:35, 19 days 23 hours ago Hospitex International initiates a feasibility study in Uzbekistan for Urine24 Feasibility Study Hospitex International Uzbekistan Urine24 Oncological Diagnoses
BRIEF published on 07/23/2026 at 07:35, 19 days 23 hours ago Hospitex International Initiates Urine24 Feasibility Study in Uzbekistan Feasibility Study Cancer Diagnostics Hospitex International Urine24 Uzbek Oncology Institute
PRESS RELEASE published on 07/23/2026 at 07:30, 19 days 23 hours ago Inside Information / Other news releases Hospitex International signs agreement with Uzbek Oncology Institute for Urine24 screening project feasibility study, confirming international interest in oncological diagnostic solutions Feasibility Study Hospitex International Urine24 Uzbek Oncology Institute Oncological Diagnostic Solutions
BRIEF published on 05/25/2026 at 19:10, 2 months 17 days ago Aliko Scientific announces a joint venture with BioBrasil for FISH probes Joint Venture Molecular Diagnostics ALIKO SCIENTIFIC BioBrasil FISH Probes
BRIEF published on 05/25/2026 at 19:10, 2 months 17 days ago Aliko Scientific and BioBrasil Form Joint Venture for FISH Probes Joint Venture Diagnostics Market ALIKO SCIENTIFIC BioBrasil FISH Probes
PRESS RELEASE published on 05/25/2026 at 19:05, 2 months 17 days ago Inside Information / Other news releases Aliko Scientific signs MOU with BioBrasil for FISH probe manufacturing JV, targeting recurring revenues and long-term profitability in global diagnostic markets Manufacturing Joint Venture ALIKO SCIENTIFIC BioBrasil FISH Probes
BRIEF published on 12/19/2025 at 18:14, 7 months 23 days ago Ikonisys Completes a Capital Increase and Debt Conversion of 2.72 Million Euros Business Expansion Capital Increase Technological Innovation Strategic Investors Mergers And Acquisitions
Published on 08/12/2026 at 00:00, 7 hours 19 minutes ago Organto Foods Reports Record Second Quarter 2026 Financial Results
Published on 08/11/2026 at 23:40, 7 hours 39 minutes ago RJK Explorations Ltd. Announces Private Placement for Gross Proceeds of up to $100,000
Published on 08/11/2026 at 23:15, 8 hours 4 minutes ago Fermi and Hillcore Energy Capital Announce 2.6 Gigawatt Power Strategic Alliance for Project Matador
Published on 08/11/2026 at 23:00, 8 hours 19 minutes ago Prospectiva Resources Ltd. Completes Qualifying Transaction
Published on 08/11/2026 at 22:55, 8 hours 24 minutes ago NV Gold Announces Non-Brokered Private Placement
Published on 08/12/2026 at 07:00, 18 minutes ago MindMaze Therapeutics Appoints Prof. John W. Krakauer as Strategic Advisor
Published on 08/12/2026 at 07:00, 18 minutes ago SCHOTT Pharma with strong third quarter and on track for planned growth
Published on 08/12/2026 at 07:00, 18 minutes ago TUI delivered resilient Q3 underlying EBIT of €234.6m (at CC), demonstrating the strength of its business despite geopolitical headwinds and one-offs, FY26 guidance reaffirmed
Published on 08/12/2026 at 07:00, 18 minutes ago E.ON remains on track and continues to invest in the energy transition
Published on 08/12/2026 at 07:00, 18 minutes ago Subdued demand weighs on Hawesko's business in the first half of the year – gross profit margin up – cost and efficiency progress taking effect – full-year 2026 guidance adjusted
Published on 08/10/2026 at 18:00, 1 day 13 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 11:53, 1 day 19 hours ago GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
Published on 08/10/2026 at 11:36, 1 day 19 hours ago GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026
Published on 08/10/2026 at 09:22, 1 day 21 hours ago Number of shares and voting rights - July 2026 (In French only)
